Systemic Lupus Erythematosus

Michelle Petri, M.D., MPH

Abstract 1025:  Lupus Atherosclerosis Prevention Study (LAPS): A Randomized Double Blind Placebo Controlled Trial of Atorvastatin Versus Placebo

Abstract 500:  Tocilizumab (Humanized Anti IL-6 Receptor Monoclonal Antibody) In Patients With Systemic Lupus Erythematosus (SLE): Safety, Tolerability And Preliminary Efficacy

Abstract 499:  Trial of Atacicept in Patients with Systemic Lupus Erythematosus (SLE)

Abstract 588. Patients with Active Systemic Lupus Erythematosus (SLE) Treated with Belimumab Improve Health-Related Quality of Life (HRQOL) in a Randomized Controlled Trial (RCT)

All information contained within the Johns Hopkins Arthritis Center website is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained within this site. Consumers should never disregard medical advice or delay in seeking it because of something they may have read on this website.

• Rheumatoid Arthritis
• Treatment Strategies
• TNF Antagonists
• B-Cell Depletion
• Other Agents
• OA Clinical Aspects
• Juvenile RA / Pediatric Rheumatology
• Systemic Lupus Erythematosus
• Vasculitis
• Scleroderma
• Fibromyalgia
• Spondyloarthropathies
• Myositis
• Pregnancy in AutoImmune Disease
• Non-Pharmacologic Management
• Basic Science
• Epidemiology
• Psychosocial